APA (7th ed.) Citation

van der Velden, D., Lagraauw, H. M., Wezel, A., Launay, P., Kuiper, J., Huizinga, T. W. J., . . . Stoop, J. N. (2016). Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. Arthritis research & therapy, 18(1), 138. https://doi.org/10.1186/s13075-016-1036-8

Chicago Style (17th ed.) Citation

van der Velden, Daniël, H. Maxime Lagraauw, Anouk Wezel, Pierre Launay, Johan Kuiper, Tom W. J. Huizinga, René E. M. Toes, Ilze Bot, and Jeroen N. Stoop. "Mast Cell Depletion in the Preclinical Phase of Collagen-induced Arthritis Reduces Clinical Outcome by Lowering the Inflammatory Cytokine Profile." Arthritis Research & Therapy 18, no. 1 (2016): 138. https://doi.org/10.1186/s13075-016-1036-8.

MLA (9th ed.) Citation

van der Velden, Daniël, et al. "Mast Cell Depletion in the Preclinical Phase of Collagen-induced Arthritis Reduces Clinical Outcome by Lowering the Inflammatory Cytokine Profile." Arthritis Research & Therapy, vol. 18, no. 1, 2016, p. 138, https://doi.org/10.1186/s13075-016-1036-8.